Fair 72°
Tag:

Clinical Study

Business
COVID-19: Pfizer Launches Clinical Trial For Vaccine Targeting Omicron Variant COVID-19: Pfizer Launches Clinical Trial For Vaccine Targeting Omicron Variant
Covid-19: Pfizer Launches Clinical Trial For Vaccine Targeting Omicron Variant New York-based Pfizer and its European partner BioNTech have launched a clinical study to evaluate a COVID-19 vaccine that specifically targets the Omicron variant. The study will evaluate the safety and efficacy of an Omicron-based vaccine among healthy adults ages 18 through 55, Pfizer announced on Tuesday, Jan. 25. According to a recent update from the Centers for Disease Control and Prevention (CDC), the Omicron variant is estimated to have accounted for 99.5 percent of circulating variants of COVID-19 in the United States between Sunday, Jan. 9, and Saturday, Jan. 15. Pfizer said up t…

SHARE

by Nicole Valinote